These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 7700003)

  • 1. Genetic approaches to understanding the pathophysiology of complex human traits.
    Williams GH
    Kidney Int; 1994 Dec; 46(6):1550-3. PubMed ID: 7700003
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A chimaeric 11 beta-hydroxylase/aldosterone synthase gene causes glucocorticoid-remediable aldosteronism and human hypertension.
    Lifton RP; Dluhy RG; Powers M; Rich GM; Cook S; Ulick S; Lalouel JM
    Nature; 1992 Jan; 355(6357):262-5. PubMed ID: 1731223
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Coexistence of different phenotypes in a family with glucocorticoid-remediable aldosteronism.
    Fallo F; Pilon C; Williams TA; Sonino N; Morra Di Cella S; Veglio F; De Iasio R; Montanari P; Mulatero P
    J Hum Hypertens; 2004 Jan; 18(1):47-51. PubMed ID: 14688810
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glucocorticoid remediable aldosteronism: low morbidity and mortality in a four-generation italian pedigree.
    Mulatero P; di Cella SM; Williams TA; Milan A; Mengozzi G; Chiandussi L; Gomez-Sanchez CE; Veglio F
    J Clin Endocrinol Metab; 2002 Jul; 87(7):3187-91. PubMed ID: 12107222
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Glucocorticoid-remediable aldosteronism.
    McMahon GT; Dluhy RG
    Cardiol Rev; 2004; 12(1):44-8. PubMed ID: 14667264
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Glucocorticoid-remediable aldosteronism (GRA): diagnosis, variability of phenotype and regulation of potassium homeostasis.
    Dluhy RG; Lifton RP
    Steroids; 1995 Jan; 60(1):48-51. PubMed ID: 7792815
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical and gene mutation studies on a Chinese pedigree with glucocorticoid-remediable aldosteronism.
    Ding W; Liu L; Hu R; Xu M; Chen J
    Chin Med J (Engl); 2002 Jul; 115(7):979-82. PubMed ID: 12150724
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular genetics of the renin-angiotensin-aldosterone system in human hypertension.
    Corvol P; Soubrier F; Jeunemaitre X
    Pathol Biol (Paris); 1997 Mar; 45(3):229-39. PubMed ID: 9296068
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A German family with glucocorticoid-remediable aldosteronism.
    Vonend O; Altenhenne C; Büchner NJ; Dekomien G; Maser-Gluth C; Weiner SM; Sellin L; Hofebauer S; Epplen JT; Rump LC
    Nephrol Dial Transplant; 2007 Apr; 22(4):1123-30. PubMed ID: 17277347
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Remediable glucocorticoid hyperaldosteronism: molecular diagnosis].
    Lurbe E; Chaves FJ; Torró I; Armengod ME; Alvarez V; Redon J
    Med Clin (Barc); 1999 Nov; 113(15):579-82. PubMed ID: 10605685
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Glucocorticoid-remediable aldosteronism in a large kindred: clinical spectrum and diagnosis using a characteristic biochemical phenotype.
    Rich GM; Ulick S; Cook S; Wang JZ; Lifton RP; Dluhy RG
    Ann Intern Med; 1992 May; 116(10):813-20. PubMed ID: 1567095
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The genetics of hypertension.
    Thibonnier M; Schork NJ
    Curr Opin Genet Dev; 1995 Jun; 5(3):362-70. PubMed ID: 7549432
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genes, hypertension, and intermediate phenotypes.
    Hollenberg NK
    Curr Opin Cardiol; 1996 Sep; 11(5):457-63. PubMed ID: 8889370
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New genetic insights in familial hyperaldosteronism.
    Jackson RV; Lafferty A; Torpy DJ; Stratakis C
    Ann N Y Acad Sci; 2002 Sep; 970():77-88. PubMed ID: 12381543
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Glucocorticoid-remediable aldosteronism.
    Williams GH; Dluhy RG
    J Endocrinol Invest; 1995; 18(7):512-7. PubMed ID: 9221269
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Variation of phenotype in patients with glucocorticoid remediable aldosteronism.
    Gates LJ; MacConnachie AA; Lifton RP; Haites NE; Benjamin N
    J Med Genet; 1996 Jan; 33(1):25-28. PubMed ID: 8825044
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular genetics of human hypertension.
    Luft FC
    J Hypertens; 1998 Dec; 16(12 Pt 2):1871-8. PubMed ID: 9886871
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetic approach to diagnostic and therapeutic decisions in human hypertension.
    Williams GH; Fisher ND
    Curr Opin Nephrol Hypertens; 1997 Mar; 6(2):199-204. PubMed ID: 9146984
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diagnosis of glucocorticoid-remediable aldosteronism in hypertensive children.
    Kamrath C; Maser-Gluth C; Haag C; Schulze E
    Horm Res Paediatr; 2011; 76(2):93-8. PubMed ID: 21625068
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genetic determination of human essential hypertension.
    Matsubara M
    Tohoku J Exp Med; 2000 Sep; 192(1):19-33. PubMed ID: 11128865
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.